H. Lundbeck A/S(HLUBF)

Research Snapshot

H. Lundbeck A/S (HLUBF) is a Healthcare stock with a market cap of $34.01B and listed on OTC. The stock last traded around $5.50 and up 48.6% across the available one-year price window (Jun 27, 2025 → Jun 25, 2026). Baseline metrics include revenue growth of +10.4%, EPS growth of +1.3%, a dividend yield of 2.7%. What stands out right now is revenue +10.4%, EPS +1.3%, free cash flow +57.0% with operating margin 26.0% and ROIC 10.0%. The dividend matters to the case here, with a current yield around 2.7%. Valuation is more restrained than many high-expectation growth names at P/E 13.3 and price/sales 1.4. Overall, the current profile looks closer to a income-oriented value setup than a generic broad-market placeholder. Stock Foundry combines HLUBF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.